scispace - formally typeset
Y

Yumin Li

Researcher at Wuhan University

Publications -  13
Citations -  5427

Yumin Li is an academic researcher from Wuhan University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 4 publications receiving 4886 citations. Previous affiliations of Yumin Li include Lanzhou University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal Article

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2459 more
- 01 Jan 2016 - 
Journal ArticleDOI

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Daniel J. Klionsky, +2522 more
- 01 Jan 2016 - 
TL;DR: Author(s): Klionsky, DJ; Abdelmohsen, K; Abe, A; Abedin, MJ; Abeliovich, H; A Frozena, AA; Adachi, H, Adeli, K, Adhihetty, PJ; Adler, SG; Agam, G; Agarwal, R; Aghi, MK; Agnello, M; Agostinis, P; Aguilar, PV; Aguirre-Ghis
Journal ArticleDOI

Visual Analysis of Colorectal Cancer Immunotherapy: A Bibliometric Analysis From 2012 to 2021

Long Ma, +3 more
- 31 Mar 2022 - 
TL;DR: “T cell”, “MMI” and “PD-1blocked” were the most widely studied aspects of CRC immunotherapy, and the United States and China were the main drivers in this field.
Journal ArticleDOI

TCR-T Immunotherapy: The Challenges and Solutions

Yating Liu, +6 more
- 25 Jan 2022 - 
TL;DR: The overall efficacy of TCR-T cell immunotherapy in solid tumors was not significantly high when compared with hematological malignancies, and the barriers and strategies affecting the efficacy were paid attention.